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license (http://creativecommons.org/Summary Background/Objective: Tanshinol is the main active component of Salvia miltior-
rhiza Bunge, a significant Traditional Chinese Medicine used to treat cardiovascular disease.
We have shown that tanshinol exerts an antiosteoporostic effect via the enhancement of bone
formation in vivo and in vitro. However, the mechanism remains unclear. Based on the poly-
phenol group in the structure of tanshinol, we speculate the protective action on skeletal tis-
sue is related to antioxidative capacity. Our in vitro evidence indicated that tanshinol
stimulated osteoblastic differentiation by its antioxidaive capacity. In this study, we aim to
further confirm the effect of tanshinol on bone formation and the underlying mechanism in
zebrafish in vivo.
Methods: We used a Danio rerio (zebrafish) model, which has a bone formation process similar
to humans, and evaluated the relationship between the dose and the effect of tanshinol on
bone formation determined using alizarin red S staining or fluorescence intensity analysis in
normal and glucocorticoid (GC)-induced inhibition of an osteogenesis model using wild-type
zebrafish and cortical bone transgenic zebrafish tg(sp7:egfp). The expression of osteoblast-
specific genes and reactive oxygen species (ROS) were tested.
Results: Our data showed that dexamethasone exerts a series of consequences, including the
inhibition of bone formation, decrease of bone mass, downregulation of expression of
osteoblast-specific genes (runx2a, ALP, osteocalcin, and sp7), as well as the accumulation ofof Pharmacology, Guangdong Key Laboratory for R&D of Natural Drug, Guangdong Medical University,
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of polyphenolic hydroxyl groups.ROS generation and decreased capacity of antioxidants. Tanshinol showed a protective effect
on promoting bone formation and bone mass both in wild-type larval zebrafish and transgenic
zebrafish. Furthermore, tanshinol attenuated the inhibition of osteogenesis elicited by oxida-
tive stress in the zebrafish exposed to dexamethasone.
Conclusion: The present findings suggest that tanshinol prevented decreased osteogenesis in
GC-treated larval zebrafish via scavenging ROS and stimulated the expression of osteoblast-
specific genes. Tanshinol treatment may be developed as a novel therapeutic approach under
recent recognised conditions of GC-induced osteoporosis.
Copyright ª 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open ac-
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
D(þ)b-3,4-dihydroxyphenyl lactic acid (tanshinol, also
called danshensu), one of the water-soluble components of
Salvia miltiorrhiza Bunge, is widely used clinically in China
as a principal active ingredient of approved drugs for
cardio-cerebral vascular diseases. Literature has high-
lighted that tanshinol can improve cardiovascular function,
promote angiogenesis, enhance microcirculation, and in-
crease blood flow velocity [1]. As a polyphenolic compound,
tanshinol shows an antioxidative effect in vivo and in vitro
owing to its two phenolic hydroxyl groups (Figure 1), and is
thought of as one of the most effective natural product
antioxidants [2e5]. Increasing pharmacological data have
indicated that tanshinol protects organisms against oxida-
tive injury [6e9]. Interestingly, previous studies in our
group have indicated that tanshinol ameliorates decreased
osteoblasitc function elicited by glucocorticoid (GC) [10].
Our further data demonstrated that the water extract of
Salvia miltiorrhiza Bunge consists mainly of tanshinol and
salvianolic acid B which are effective in preventing bone
loss in rats treated by prednisone [11]. Our recent data
further proved that tanshinol attenuates oxidative stress-
triggered inhibition of osteoblasitc differentiation [12].
Taken together, as a definite agent to treat cardio-cerebral
vascular diseases, tanshinol may be developed as a safe and
effective candidate for the treatment of bone disorders
including osteoporosis.
Previous evidence reveals a strong relationship between
low bone mass and relative risk for cardiovascular disease
in postmenopausal women [13]. Further results showednshinol. Tanshinol consiststhat osteoblasts regulate bone marrow angiogenesis in the
process of bone metabolism [14]. Recent data identified a
new capillary subtype in the murine skeletal system,
coupling angiogenesis with osteogenesis [15]. Interestingly,
oxidised lipids accelerate atherogenesis and simutaneously
restrain osteoblastic differentiation leading to low bone
mineral density [16]. New evidence revealed that oxidative
stress elicited by the reaction of the termed advanced-
glycation end products and its receptor contributes to the
progression of osteoporosis and cardiovascular diseases
[17]. Currently, oxidative stress is a widely accepted
participant in the pathogenesis of osteoporosis [18].
Therefore, oxidative stress might be developed as a novel
therapeutic intervention in osteo-vascular disorders.
Long-term excessive administration of GC is commonly
used in the treatment of autoimmune and inflammatory
diseases, and often leads to glucorcoticoid-induced osteo-
porosis (GIO). Previous data highlight that dexamethasone
(Dex) can directly or indirectly induce oxidative stress
through either inhibition of antioxidant activities or in-
duction of excessive production of reactive oxygen species
(ROS) [19]. Oxidative stress hinders osteoblastic differen-
tiation by virtue of the consequence of osteoblastic
apoptosis, responsible for the impaired bone formation
[20]. Therefore, excessive GC may substantially contribute
to bone loss owing to oxidative stress. To date, the medi-
cations which control GIO clinically are similar to those
used for the treatment of postmenopausal osteoporosis,
with different pathological process characterised by the
increase in the number and functions of osteoclasts, such as
bisphosphonates, raloxifene, parathyroid hormone, and
hormone replacement. These agents cannot solve the
skeletal problems of the multifactor driven GIO [21,22],
especially under the condition of oxidative stress. Urgently,
there is a pressing need to search for an effective thera-
peutic drug to prevent and treat GIO.
Notwithstanding murine animal models of GIO applied
for many years, there are a dozen experimental short-
comings for the research and development of new drugs,
including long cycles, large expense, high labour-intensity,
etc. In addition, according to the evidence of our labora-
tory, very distinct bone loss was not detectable in GIO rats
[23]. Danio rerio (zebrafish), however, has recently been
developed as an ideal animal model characterised by small
size and short generation time. In particular, it is suitable
for the screening of antiosteoporotic agents because of
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bone metabolism, and signalling pathways [24,25]. For the
past decade, a significant delay in the early process of
mineralisation was observed in the zebrafish embryo of AB
wild-type strains exposed to prednisolone [26]. Hereafter,
there are now increasing documents focused on bone for-
mation in zebrafish [27e29]. To monitor directly the bone
formation status, our team adopted a transgenic zebrafish,
named tg(sp7:egfp) zebrafish, in which bone tissue ex-
presses green fluorescent protein (GFP) under the control
of promoters for the preosteoblast intermediate marker
osterix (sp7) [29,30].
Based on the lines of evidence above, we used juvenile
wild-type zebrafish and tg(sp7:egfp) zebrafish as in vivo
models to investigate the effects of GC on the dysfunction
of bone formation, and to determine the relationship be-
tween the dose of tanshinol and its efficacy to intervene
abnormal bone metabolism triggered by GC. Meanwhile, we
will testify the hypothesis that tanshinol can enhance bone
formation via the regulation of gene expression associated
with bone metabolism, and attenuate GC-induced inhibi-
tion of osteogenesis via the protection of skeletal tissue
from oxidative stress. Tanshinol may be developed as a
potential candidate for the prevention and/or treatment of
osteoporosis.
Materials and methods
Animal husbandry
Wild type zebrafish (AB strain) and osterix:nlsGFP trans-
genic zebrafish [tg(sp7:egfp)] were treated under standard
procedures [31]. Adult zebrafish mate and spawn naturally
under the condition of day to night-time controlled at 14:10
hours. The zebrafish embryos and larvae of AB strain and
tg(sp7:egfp) were cultured in egg water (5mM NaCl,
0.17mM KCl, 0.4mM CaCl2, 0.16mM MgSO4, and 10 ppm
methylene blue) containing 30 ppm N-phenylthiourea and
in egg water without N-phenylthiourea under isothermal
conditions at 28.5C, respectively.
Preparations of agent solution
Dex (MP, USA) and Calcitriol Soft Capsule (Rocalirol; Roche,
Switzerland) were dissolved in dimethyl sulphoxide (DMSO;
Sigma-Aldrich, Japan) as stock solution at a concentration
of 10mM and 6  106 mg/mL, respectively, and were stored
at 20C. Tanshinol (Tianjingshilang, China) was identified
and its content was determined using high performance
liquid chromatography (HPLC; Agilent, USA; tanshinol with
content of 90%) with the standard reference (National In-
stitutes for Food and Drug Control, Beijing, China). Tan-
shinol was diluted to a final concentration of 50mM in egg
water before use.
Experimental designs
At 3 days’ post-fertilization (dpf), zebrafish larvae were
raised in egg water in 24-well plates and randomly divided
into the following groups (n Z 12 larvae/2 wells/group).For detection of the role of tanshinol in the process of bone
formation, the following concentrations were used: (1)
control; (2) 0.5mM tanshinol (T0.5); (3) 1mM tanshinol (T1);
(4) 2.5mM tanshinol (T2.5); and (5) 5mM tanshinol (T5). For
the investigation of the role of tanshinol in osteogenesis in
zebrafish larvae exposed to Dex, the following treatments
were executed: (1) vehicle control (0.1% DMSO); (2) 10mM
Dex; (3) Dex þ 1mM tanshinol (DþT1); (4) Dex þ 2.5mM
tanshinol (DþT2.5); (5) Dex þ 5mM tanshinol (DþT5); (6)
Dex þ 10mM tanshinol (DþT10); (7) Dex þ 50mM tanshinol
(D þ T50); and (8) Dex þ 6  106 mg/mL rocalirol (DþR).
During 3-dpf and 9-dpf, the stock solution of agents were
diluted in egg water as indicated. The final volumes of
medium/well were adjusted to 1 mL, and 50% of the me-
dium of each well was replaced every day. At 9-dpf,
zebrafish larvae were collected. The AB strains were
stained with alizarin red (MP, USA), and tg(sp7:egfp) were
measured using green fluorescence of head bone, respec-
tively. For quantitative real-time polymerase chain reac-
tion (qRT-PCR) analysis and oxidative stress assay, 3-dpf
zebrafish larvae were transferred into six-well plates and
randomly divided into three groups (n Z 90 larvae/3 well/
group) as follows: (1) vehicle control (0.1% DMSO); (2) 10mM
Dex; and (3) Dex þ 5mM tanshinol. Determinations were
performed at 9-dpf after the treatment outlined above.
Alizarin red staining
Bone mineralised matrix deposition, an important indicator
of bone formation, was evaluated using alizarin red stain-
ing. Alizarin red, a dye which can attach specifically to
calcium salts, is widely used to observe and measure min-
eralisation of bone. At 9-dpf, zebrafish larvae AB strain
were collected and fixed for 2 hours in a 4% parformalde-
hyde solution, then stained with 0.1% alizarin red (MP, USA)
in 0.5% potassium hydroxide as described in previous papers
[32]. Larval heads were placed on a slide as previously re-
ported [26], and images of the dorsal aspect head bone of
zebrafish larvae was photographed using a M205 FA stereo
microscope (Leica, Germany) equipped with a DFC310 FX
camera (Leica, Germany). The area and integral optical
density (IOD) of alizarin red staining were determined using
Image-Pro Plus image analysis software version 6.0 (Media
Cybernetics, USA). More than nine pieces of zebrafish were
used in each group.
Fluorescence imaging
Because the osteoblasts of tg(sp7:egfp) zebrafish express
GFP, osteoblast differentiation and bone formation can be
directly observed and assessed via fluorescence micro-
scopy. After being fixed in 4% parformaldehyde solution for
2 hours, the bodies of 9-dpf tg(sp7:egfp) zebrafish were
divided into two sections. The head was placed in a
confocal laser special glass-bottom dish, wrapped in 1%
low-melting agarose gel. The fluorescence of GFP in the
dorsal aspect head bone tissues of larvae was visualised
using a TCS SP5Ⅱconfocal lasers canning microscopy (LSCM,
Leica, Germany). High-resolution confocal fluorescence
images were analysed using Image-Pro Plus image analysis
software version 6 (Media Cybernetics, USA). Fluorescence
38 S. Luo et al.images were converted to greyscale images, and the fluo-
rescence intensity was converted to grey value. An in-
tensity range was set to include all grey localisations, and
the area and the density of this grey localisation were
calculated. The same intensity range was applied to all
images of larvae. More than nine pieces of zebrafish were
used in each group.
qRT-PCR assay
Total RNA from each group of zebrafish larvae (n Z 10
larvae/group) was extracted using Trizol reagent (Abcam,
USA) according to the manufacturer’s instructions. Com-
plementary DNA was synthesised using SuperScript II
reverse transcriptase (Invitrogen, USA). qRT-PCR was per-
formed using Roche LightCycler 480 QPCR System (Roche,
Switzerland). Paired primers of osteoblast-specific genes
(runx2a, ALP, OC, and sp7) are listed in Table 1. The data
generated were analysed for cycle threshold (Ct) values
using the accompanying Opticon Monitor software. Relative
mRNA expression was quantified by subtracting the b-actin
Ct value from the Ct value of the genes of interest and
expressed as 2OCt, as described by the protocol of the
manufacturer (n Z 3).
Oxidative stress assay
To express the action of tanshinol on rescued osteogenesis
under oxidative stress elicited by GC, the indices of
oxidative stress including ROS, superoxide dismutase (SOD),
malonic dialdehyde (MDA), glutathione peroxidase (GSH),
and hydrogen peroxidase (catalase, CAT) were measured
using chemical colourimetry according to the manufac-
turer’s instructions (Beyotime Institute of Biotechnology, or
Nanjin Jianchen Bioengineering Institute, China). Briefly, 9-
dpf zebrafish larvae were washed twice using ultrapure
water, and homogenised in 500 mL ultrapure water with a
glass homogeniser. The homogenate was centrifuged and
the supernatant was collected and stored at 20C until
the assay was performed.
Statistical analysis
Statistical analysis was performed using SPSS version 16.0
(IBM Corp, NY, USA). Data are presented as
mean  standard deviation, or mean  standard error of
the mean. The statistical differences among various treat-
ments were tested using one-way analysis of variance with
Fisher’s Least Significant Difference test if the data were
normally distributed and had equivalency of variances.
Otherwise, Dunn’s method for post hoc test was used toTable 1 Primer sequences for quantitative real-time polymera
mRNA Forward sequence (50e30)
runx2a GACTCCGACCTCACGACAA
sp7 AAGAAACCTGTCCACAGCTG
ALP CAGTGGGAATCGTCACAACAA
OC TGGCCTCTATCATCATGAGACAperform pairwise comparisons of the treatment groups. If
probabilities were less than 0.05 (p < 0.05), statistical
differences were considered significant.
Results
Effect of tanshinol on bone mineralisation in intact
zebrafish larvae AB strain
In order to test the effects of tanshinol on zebrafish larval
bone formation, zebrafish larvae AB strain were exposed to
tanshinol in the increasing concentrations (0.5mM, 1mM,
2.5mM, and 5mM) during 3-dpf and 9-dpf. As shown in
Figure 2, the area and IOD of head bone stained with aliz-
arin red was increased in intact zebrafish larvae treated
with tanshinol (>0.5mM) compared with the control
(p < 0.05). However, tanshinol at the concentrations of
1mM, 2.5mM, and 5mM exerted the same action to promote
the increase of the area and IOD of head bone in zebrafish
larvae. The data suggests that tanshinol can promote bone
formation of cranial bones in zebrafish larval.
Effect of tanshinol on bone mineralisation in
zebrafish larvae AB strain treated by Dex
To investigate whether tanshinol can prevent GC-induced
inhibition of osteogenesis, zebrafish larvae AB strain during
3-dpf and 9-dpf were treated with tanshinol (1mM, 2.5mM,
5mM, 10mM, and 50mM) in the presence of 10mM Dex. Ac-
cording to the results shown in Figure 3, 10mM Dex elicited a
significant decrease of the area and IOD stained with aliz-
arin red in larval skull compared with the control, rocalirol,
as a positive control reversed the decrease of the stained
area and IOD. Mostly, tanshinol in dosages ranging from
2.5mM to 50mM hampered the inhibition of Dex on the area
and IOD of the cranial bone in zebrafish larvae, reaching the
climax of the impact at the concentration of 5mM. The
result indicates that tanshinol attenuates the Dex-induced
inhibition of bone mineralisation in zebrafish larvae.
Effect of tanshinol on osteoblastic differentiation
in tg(sp7:egfp) zebrafish
Encouraged by the findings above, we proceeded to explore
the action of tanshinol on osteoblastic differentiation in
tg(sp7:egfp) zebrafish larvae expressing fluorescent pro-
teins under control of the promoter osterix (sp7), a tran-
scription factor of osteoblastic differentiation. As is shown
in Figure 4, tanshinol at the concentrations of 1mM, 2.5mM,
and 5mM exerts a significant positive effect on these chain reaction.
Reverse sequence (50e30)
CGTCCCGTCAGGAACATC
GAGGCTTTACCGTACACCTT
CCACACAGTGGGCATAAGCA
GA CTCTCGAGCTGAAATGGAGTCA
Figure 2 Effects of tanshinol on bone mineralisation of wild-type AB strains zebrafish larval skull. Images of (A) the dorsal aspect
head bone stained with alizarin red in wild-type AB strains zebrafish larvae at 9 days’ postfertilisation (dpf) with or without
exposure to tanshinol (0.5mM, 1mM, 2.5mM, 5mM); (B) the effect of tanshinol on bone mineralisation area in 9-dpf zebrafish; and (C)
the effect of tanshinol on bone mineralisation integral optical density in 9-dpf zebrafish. ConZ control, egg water; IODZ integral
optical density; T0.5 Z tanshinol 0.5mM; T1 Z tanshinol 1mM; T2.5 Z tanshinol 2.5mM; T5 Z tanshinol 5mM. Data are given as
mean  standard deviation (n  9). *p < 0.05 versus control.
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zebrafish larvae at 9-dpf treated as zebrafish AB above,
using confocal lasers canning microscopy. Results of quan-
titative analysis further indicated that treatment with 1mM
tanshinol lead to the maximal intensity of green fluores-
cence area and IOD of head bone in tg(sp7:egfp) zebrafish
larvae. The data suggest that tanshinol stimulates osteo-
blasts differentiation in tg(sp7:egfp) zebrafish larvae.Effect of tanshinol on osteoblastic differentiation
in tg(sp7:egfp) zebrafish treated by Dex
Cellular responses induced by Dex may contribute to the
suppression of osteoblastic differentiation in zebrafish.
Therefore, we examined the protective action of tanshinol
(1mM, 2.5mM, 5mM, 10mM, and 50mM) on osteoblastic dif-
ferentiation measured by the area and intensity of Sp7
green fluorescence in tg(sp7:egfp) zebrafish at 9-dpf. As is
shown in Figure 5, tg(sp7:egfp) zebrafish treated with 10mM
Dex exhibited a reduction in the fluorescence area and IOD,
which was blocked by rocalirol. In line with the evidence
achieved from zebrafish larvae AB strain, tanshinol
(2.5e50mM) hampered the inhibition of Dex on the fluo-
rescence area and IOD in zebrafish larvae, especially at the
concentration of 5mM. The results suggest that tanshinol
ameliorates Dex-elicited inhibition of osteoblastic differ-
entiation in tg(sp7:egfp) zebrafish.Tanshinol attenuates Dex-elicited downregulation
of osteoblast-specific genes expression in zebrafish
To further investigate the protective influence of tanshinol on
the process of bone formation under conditions of Dex treat-
ment, the alteration of expressions of osteoblast-specific
geneswas determined using qRT-PCR assay in zebrafish larvae
exposed to 10mM Dex. As shown in Figure 6, zebrafish larvae
treated with Dex showed a trend toward reduction of the
expression of osteoblast-specific genes, including runx2a,
osteocalcin (OC), ALP, and osterix (sp7), compared with the
corresponding control. Importantly, tanshinol counteracted
the downregulation of osteoblast-specific genes elicited by
Dex. The evidence suggests that tanshinol rescues the
decreased bone formation triggered by Dex.
Effect of tanshinol on oxidative stress in zebrafish
Intracellular ROS products are thought of widely as an early
response to oxidant stimuli, following a series of delete-
rious molecule events for oxidative stress. Notwithstanding
the inhibitory impact of Dex on osteoblasitc differentiation
and bone formation of cranial bones in zebrafish larvae, we
next ask whether Dex induced oxidative stress in zebrafish
larvae contributes to decreased bone metabolism. As ex-
pected, zebrafish larvae exposed to Dex exhibited a
remarkable increase of ROS accumulation measured using
an oxidation-sensitive fluorescent probe dye, DCFH-DA
Figure 3 Protective effects of tanshinol on head bone mineralisation of wild-type AB strains zebrafish larval exposed to dexa-
methasone (Dex). Images of (A) the dorsal aspect head bone stained with alizarin red in wild-type AB strains zebrafish larvae at
9 days’ postfertilisation (dpf) exposed to Dex (10mM) in the presence or absence of tanshinol; (B) the effect of tanshinol on bone
mineralisation area in 9-dpf zebrafish exposed to Dex; and (C) the effect of tanshinol on bone mineralisation integral optical density
in 9-dpf zebrafish exposed to Dex. Dex Z Dex 10mM; DþR Z Dex þ rocalirol 6  106 mg/mL); DþT1 Z Dex þ tanshinol 1mM;
DþT2.5 Z Dex þ tanshinol 2.5mM; DþT5 Z Dex þ tanshinol 5mM; DþT10 Z Dex þ tanshinol 10mM; DþT50 Z Dex þ tanshinol 50mM;
IOD Z integral optical density; Veh Z vehicle control, 0.1% dimethyl sulphoxide. Data are given as mean  standard deviation
(n  9). *p < 0.05 versus vehicle control. **p < 0.05 versus Dex treatment.
40 S. Luo et al.(Beyotime institute of Biotechnology, China), in line with an
increase of MDA level (Figure 7A and B). Meanwhile, the
activities of SOD, glutathione peroxidase, and CAT showed a
significant trend toward reduction in zebrafish larvae
treated by Dex. By contrast, tanshinol hampered these al-
terations of ROS generation and MDA level initiated by Dex.
However, the protective effect of tanshinol on antioxidants
mentioned above had no statistical difference compared
with the control (Figure 7C, D, and E). Based on the results
of our present study, tanshinol diminishes oxidative stress
stimulated by Dex in zebrafish larvae.Discussion
Extensive studies highlight that the increase of oxidative
stress in skeletal tissue impairs osteoblastic differentiationand bone formation, contributing to osteoporosis, which
might be hampered by antioxidants [12]. Tanshinol, as a
natural antioxidant, is the main effective chemical
composition of many clinical therapeutic agents for cardio-
cerebro vascular diseases. Previous evidence in our team
demonstrated that tanshinol in vitro can stimulate the
function of differentiation, proliferation, and mineralisa-
tion in osteoblasts, and ameliorate GC-induced bone
marrow stromal cell adipogenesis [10,12]. In the present
work, further evidence demonstrates that tanshinol exerts
a positive effect on the function of osteoblasitc differen-
tiation and mineralisation both in intact zebrafish larvae AB
strain and in tg(sp7:egfp) zebrafish. Meanwhile, tanshinol
rescues impaired osteogenesis elicited by Dex, involved in
hampering the downregulation of gene expression related
to bone formation in zebrafish exposed to Dex, contributing
to the protective impact on skull formation. Additionally,
Figure 4 Effects of tanshinol on osteoblasts differentiation in tg(sp7:egfp) zebrafish larvae. Fluorescence images of (A) the
dorsal aspect measured using laser scanning confocal microscopy in tg(sp7:egfp) zebrafish larvae at 9 days’ postfertilisation (dpf)
with or without tanshinol (0.5mM, 1mM, 2.5mM, 5mM). (B) Effect of tanshinol on green fluorescence area of 9-dpf tg (sp7:egfp)
zebrafish. (C) Effect of tanshinol on green fluorescence integral optical density of 9-dpf tg (sp7:egfp) zebrafish. ConZ control, egg
water; IOD Z integral optical density; T0.5 Z tanshinol 0.5mM; T1 Z tanshinol 1mM; T2.5 Z tanshinol 2.5mM; T5 Z tanshinol 5mM.
Data are given as mean  standard deviation (n  9). )p < 0.05 versus vehicle control.
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increased MDA levels, resulting in antioxidative stress in-
fluence under the conditions of Dex in zebrafish. The find-
ings, herein, reveal that tanshinol diminishes the
deleterious effects of GC on skeletal tissue during bone
formation in zebrafish owing to antioxidative effect.
Based on the present data, we found that the effective
concentration of tanshinol to stimulate osteogenesis in
zebrafish treated by a vehicle control differs from zebrafish
exposed to Dex. In accordance with our previous finding
in vitro [12], tanshinol at a concentration of 1mM is bene-
ficial to the stimulation of osteogenesis in zebrafish; how-
ever, it exerts no significant action on osteoblastic
differentiation and bone formation in either wild-type
zebrafish or tg(sp7:egfp) zebrafish in the presence of Dex,
whereas 5mM tanshinol is the optimal concentration. The
reasons for this difference may involve more molecules of
tanshinol being needed to deal with the complicated situ-
ation in the two types of zebrafish exposed to Dex, how-
ever, it should be investigated in detail. Moreover, we
found that zebrafish larvae treated with Dex (5e20mM)
show a dose-dependent inhibition of skull formation, and
10mM Dex is more appropriate without death (the data not
shown). According to these finding, 5mM tanshinol was
taken as a feasible experimental dose to explore the gene
expression related to osteogenesis and antioxidative effect
in zebrafish larvae treated with Dex at the optimal con-
centration of 10mM.The present evidence confirms that tanshinol with
polyphenolic hydroxyl groups in the structure exerts the
inhibitory action on oxidative stress, in line with our pre-
vious finding in C2C12 cells treated with H2O2 [12]. Actually,
GC has been described as an oxidant stimulus in previous
publications, to which oxidative stress is a susceptive
response in skeletal tissue [19,33,34] Our evidence dem-
onstrates that Dex initiates excessive ROS accumulation
and increased MDA, and simultaneously leads to inhibition
of the activity of the anxioxdants including SOD, GSH, and
CAT in zebrafish larvae. However, the present data shows
that tanshinol diminishes the increase of ROS products and
MDA levels, and it exerts no effect statistically on the ac-
tivities of these antioxidants. The finding suggests that
tanshinol, as a strong antioxidant, may fight directly against
oxidative stress by itself in zebrafish, instead of the upre-
gulation of the endogenous antioxidants. The mechanism
remains to be elucidated. Our previous data revealed that
water extract of danshen consists mainly of tanshinol and
salvianolic acid B, and helps to promote the expressions of
runx2 and b-catenin mRNA and block Dickkopf 1 and
peroxisome proliferator-activated receptor mRNA, which
contributes to the beneficial influence on osteoblastic dif-
ferentiation in vitro [11]. Moreover, our new finding showed
that tanshinol attenuates oxidative stress via the down-
regulation of FoxO3a signalling, and rescues the decrease
of osteoblastic differentiation through the upregulation of
Wnt signal under oxidative stress in C2C12 cells [12]. In this
Figure 5 Protective effects of tanshinol counteracting dexamethasone (Dex)-induced inhibition of osteoblasts differentiation in
tg(sp7:egfp) zebrafish larvae. (A) Fluorescence images of the dorsal aspect measured with laser scanning confocal microscopy in
tg(sp7:egfp) zebrafish larvae at 9 days’ post fertilisation (dpf) exposure to Dex (10mM) in the presence or absence of tanshinol. (B)
Effect of tanshinol on fluorescence area in 9-dpf tg (sp7:egfp) zebrafish exposed to Dex. (C) Effect of tanshinol on fluorescence
integral optical density in 9-dpf tg (sp7:egfp) zebrafish exposed to Dex. Dex Z Dexamethasone 10mM;
DþRZ Dex þ rocalirol 6  106 mg/mL; DþT1Z Dex þ tanshinol 1mM; DþT2.5Z Dex þ tanshinol 2.5mM; DþT5Z Dex þ tanshinol
5mM; DþT10Z Dex þ tanshinol 10mM; DþT50Z Dex þ tanshinol 50mM; IODZ integral optical density; VehZ vehicle control, 0.1%
dimethyl sulphoxide. Data are given as mean  standard deviation (n  9). *p < 0.05 versus vehicle control. **p < 0.05 versus Dex
treatment.
42 S. Luo et al.study, we confirmed that tanshinol hampers Dex-initiated
downregulation of expression of osteoblast-specific genes,
including of runx2a, osteocalcin, ALP, and osterix in
zebrafish larva. Collectively, tanshinol rescues decreased
bone formation via diminishing the dysregulation of
osteoblast-specific genes and attenuates oxidative stress
elicited by Dex.
Zebrafish is a new type of ideal model which possesses
several advantages, including extrauterine development,
small size, short generation time, optically transparent
embryos, strong regeneration ability, and genomic conser-
vation between zebrafish and humans [35]. By contrast,
rodential animals such as rats, mice, and rabbits have too
many limitations including long cycles, large expense, high
labour-intensity, limited sensitivity, and unsuitable testingfor trace ingredients [23,36]. In particular, zebrafish had a
high similarity with humans in terms of bone architecture,
bone cells, matrix proteins, and molecular signalling, suit-
able for the screening of agents to prevent and treat
osteoporosis [24e29]. Moreover, the cranial bone of
zebrafish larvae develops in approximately 1 week from 3-
dpf to 9-dpf with two kinds of osteogenesis similar to
humans, including endochondral and intramembranous
ossification [37]. Interestingly, literature reported previ-
ously that there are few tartrate-resistance acid phospha-
tase (a specificity marker enzyme of differentiation and
bone resorption of osteoclast)-positive osteoclasts
observed in zebrafish larvae until 20-dpf [38,39], which
indicates that there is osteogenesis or bone formation,
however, there is few bone remodelling in zebrafish larvae.
Figure 6 Effect of tanshinol on the expressions of osteoblast-specific genes in zebrafish larvae exposed to dexamethasone (Dex).
mRNA levels of (A) runx2a; (B) alp; (C) OC; and (D) sp7 genes in experimental groups were determined with quantitative real-time
polymerase chain reaction. Dex Z dexamethasone 10mM; DþT Z Dex þ tanshinol 5mM; Veh Z vehicle control, 0.1% dimethyl
sulfoxide. Date are given as mean  standard error of the mean of three independent experiments. *p < 0.05 versus vehicle
control. **p < 0.05 versus Dex treatment.
Figure 7 Protective effects of tanshinol against dexamethasone-induced oxidative stress level in zebrafish larvae. (A) The
accumulation of reactive oxygen species; (B) malondialdehyde level; and the activities of (C) superoxide dismutase; (D) gluta-
thione; and (E) catalase were determined as methods described in oxidative stress assay section of Materials and methods.
CAT Z catalase; Dex Z dexamethasone 10mM; DþT Z Dexþtanshinol 5mM; GSH Z glutathione; MDA Z malondialdehyde;
SOD Z superoxide dismutase; Veh Z vehicle control, 0.1% dimethyl sulphoxide. Data are given as mean  standard error of the
mean of three independent experiments.*p < 0.05 versus vehicle control. **p < 0.05 versus Dex treatment.
Inhibition of osteogenesis in larval zebrafish 43
44 S. Luo et al.Therefore, zebrafish larvae might be more suitable for the
research and development of anabolic agents for GIO than
other models. Despite the numerous advantages listed
above, bone formation of skull cannot be directly observed
in the model of wild-type zebrafish larvae, and it is a fine
and complicated procedure to stain in a tiny model. In
transgenic zebrafish tg(sp7:egfp), sp7 gene is expressed
accompanying GFP expression in the process of osteoblast
differentiation, and GFP-positive osteoblasts are visible in
zebrafish. Therefore, tg(sp7:egfp) can be used to monitor
bone formation directly without the shortcomings of wild
type zebrafish mentioned above [32]. We have investigated
the capacity of osteogenesis of cranial bones in the two
types of zebrafish larvae in the study.
In summary, the present evidence indicates that tan-
shinol protects organisms against oxidative stress elicited
by Dex via scavenging excessive accumulation of ROS gen-
eration, and simultaneously attenuates the inhibitory ef-
fect of Dex on osteoblastic differentiation and mineral bone
formation of cranial bone via hampering of the dysregula-
tion of osteoblastic-specific genes in wild-type zebrafish
larvae and in tg (sp7:egfp) zebrafish larvae. In fact, tan-
shinol with the phenolic hydroxyl group exerts therapeutic
efficacy in cardio-cerebral vascular diseases for 10 years as
reported in clinical practice of China, owing to strong
antioxidative and antiapoptotic actions on cells and tissues
[11,12,40]. Based on our previous evidence, tanshinol ex-
hibits a significant protective influence on skeletal tissue,
and may be developed as a safe and effective candidate for
the prevention of and therapeutic applications in bone
disorders including osteoporosis. The action of tanshinol in
relation to the stimulation of bone formation is taken as an
acceptable anabolic pharmacological benefit, exhibiting an
inspiring trend in the research and development of thera-
peutic agents for GIO.
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